Dopamine Agonists and Risk of Lung Cancer in Patients with Restless Legs Syndrome.
Sign Up to like & getrecommendations! Published in 2023 at "Pharmacoepidemiology and drug safety"
DOI: 10.1002/pds.5596
Abstract: To examine the association between long‐term use of dopamine agonists (DAs) and the risk of lung cancer in patients with restless legs syndrome (RLS). read more here.
Keywords: lung cancer; patients restless; cancer patients; restless legs ... See more keywords
The Role of Dopamine Agonists in Pituitary Adenomas.
Sign Up to like & getrecommendations! Published in 2020 at "Endocrinology and metabolism clinics of North America"
DOI: 10.1016/j.ecl.2020.05.006
Abstract: Dopamine agonist therapy is the primary therapy for prolactin-secreting adenomas and usually results in normoprolactinemia, eugonadism, and tumor reduction. Cabergoline is superior to bromocriptine with regard to efficacy and tolerance. Withdrawal of cabergoline can be… read more here.
Keywords: dopamine agonists; agonists pituitary; pituitary adenomas; cabergoline ... See more keywords
Hyperprolactinemia after menopause: Diagnosis and management.
Sign Up to like & getrecommendations! Published in 2021 at "Maturitas"
DOI: 10.1016/j.maturitas.2021.06.014
Abstract: Most prolactinomas are diagnosed in women of reproductive age and are generally microadenomas. Prolactinomas diagnosed in postmenopausal women are less common and are not usually associated with the typical syndrome induced by prolactin excess, including… read more here.
Keywords: dopamine agonists; management; menopause diagnosis; hyperprolactinemia menopause ... See more keywords
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists
Sign Up to like & getrecommendations! Published in 2020 at "Molecular and Cellular Endocrinology"
DOI: 10.1016/j.mce.2020.111033
Abstract: Dopamine agonists (DAs), such as cabergoline and bromocriptine, are the first-line clinical treatment for prolactinomas. Our previous study demonstrated that long noncoding RNA H19 expression is frequently downregulated in human primary pituitary adenomas and is… read more here.
Keywords: long noncoding; dopamine agonists; expression; treatment prolactinomas ... See more keywords
Use of dopamine agonists to target angiogenesis in women with endometriosis.
Sign Up to like & getrecommendations! Published in 2020 at "Human reproduction"
DOI: 10.1093/humrep/deaa337
Abstract: Endometriosis requires medical management during a woman's reproductive years. Most treatments aim to create a hypoestrogenic milieu, but for patients wishing to conceive, drugs that allow normal ovarian function are needed. Targeting angiogenesis, a hallmark… read more here.
Keywords: use dopamine; endometriosis; dopamine agonists; women endometriosis ... See more keywords
Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15660
Abstract: Dopamine agonists are a key tool in the therapeutic arsenal of endocrinologists worldwide. They exert their effects by binding to dopamine‐2 (D2) receptors expressed by pituitary tumour cells to modulate hormonal secretion and tumour size.… read more here.
Keywords: treatment pituitary; next generation; pituitary tumours; treatment ... See more keywords
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
Sign Up to like & getrecommendations! Published in 2021 at "Parkinson's Disease"
DOI: 10.1155/2021/9952743
Abstract: Objective To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for… read more here.
Keywords: mao inhibitor; dopamine agonists; mao inhibitors; dopamine agonist ... See more keywords
Advances in the Therapeutic Use of Non-ergot Dopamine Agonists in the Treatment of Motor and Non-motor Symptoms of Parkinson's Disease.
Sign Up to like & getrecommendations! Published in 2022 at "Current neuropharmacology"
DOI: 10.2174/1570159x20666220915091022
Abstract: Dopamine (DA) agonists, as an excellent dopamine replacement therapy for patients with early and advanced Parkinson's disease (PD), play a vital role in controlling motor and several non-motor symptoms. Besides, the application of DA agonists… read more here.
Keywords: motor symptoms; non motor; parkinson disease; non ergot ... See more keywords
A Review of Voltammetric Methods for Determination of Dopamine Agonists
Sign Up to like & getrecommendations! Published in 2020 at "Current Analytical Chemistry"
DOI: 10.2174/1573411016999200526130915
Abstract: Dopamine agonists are useful drugs for the management of patients with Parkinson's disease in the early stages and in later stages of the disease. Parkinson's disease is a progressive neurodegenerative disease that primarily affects dopamine-producing… read more here.
Keywords: determination dopamine; voltammetric methods; dopamine agonists; methods determination ... See more keywords
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.791633
Abstract: Pituitary neuroendocrine tumors (PitNET) are commonly benign tumors accounting for 10-25% of intracranial tumors. Prolactin-secreting adenomas represent the most predominant type of all PitNET and for this subtype of tumors, the medical therapy relies on… read more here.
Keywords: pitnet; molecular mechanisms; therapy; resistance ... See more keywords